Innoviva, Inc. — Director's Dealing 2015

Nov 23, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2015-11-20

Reporting Person: dEsparbes Eric (SVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-20	Common Stock	F	7940	$8.92	Disposed	132779	Direct

Footnotes

F1: These shares were withheld by the Company to satisfy income tax withholding obligations associated with quarterly vesting of previously granted employee equity awards.

F2: Includes 1,276 shares of common stock acquired under the Theravance, Inc. Employee Stock Purchase Plan on November 15, 2015.